UBS’s Lombard Medical, Inc. EVAR Stock Holding History

UBS’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$10K	Buy	1,268 +686	+118%	+$4.54K	﹤0.01%	8876
2014 Q2	$4K	Buy	+582	New	+$4.74K	﹤0.01%	9739

Other funds holding EVAR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

UBS's EVAR Position: Q3 2014 in Review

UBS increased its Lombard Medical, Inc. (EVAR) stake by 118% in Q3 2014, buying an estimated $4.54K and bringing the position to 1,268 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #8876.

UBS first reported a position in EVAR in Q2 2014 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold EVAR as of Q3 2014.

UBS held 1,268 shares of Lombard Medical, Inc. worth $10K as of Q3 2014.
UBS bought 686 Lombard Medical, Inc. shares in Q3 2014, an estimated $4.54K.
Lombard Medical, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8876 holding.
UBS first reported a position in Lombard Medical, Inc. in Q2 2014 and has held it in 2 quarters since.
20 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.